Peng Zeng

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4+ neutrophils and S100A8+ monocytes.

Single-cell and spatial transcriptomics reveal that the CXCL12-CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4+ neutrophils and S100A8+ monocytes.

Journal: Journal for immunotherapy of cancer

Published: April 03, 2026

Desmoid tumor mimicking cancer recurrence in a patient with colon cancer and Gardner syndrome: A case report.

Desmoid tumor mimicking cancer recurrence in a patient with colon cancer and Gardner syndrome: A case report.

Journal: SAGE open medical case reports

Published: February 10, 2026

Near-Infrared Fluorescent Probes Targeting LAG-3 for Guiding Immunomodulation and Efficacy Monitoring of Stereotactic Body Radiotherapy in Liver Cancer.

Near-Infrared Fluorescent Probes Targeting LAG-3 for Guiding Immunomodulation and Efficacy Monitoring of Stereotactic Body Radiotherapy in Liver Cancer.

Journal: Journal of hepatocellular carcinoma

Published: December 30, 2025

Identification of a Novel TIM-3 Targeting Peptides Probe to Indicate the Immunomodulation of SBRT Combined with Anti-TIM-3 Therapy in HCC.

Identification of a Novel TIM-3 Targeting Peptides Probe to Indicate the Immunomodulation of SBRT Combined with Anti-TIM-3 Therapy in HCC.

Journal: Molecular imaging and biology

Published: July 04, 2025

A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy 125I Seed Enhances Anticancer Efficacy by Rescuing Immune Escape.

A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy 125I Seed Enhances Anticancer Efficacy by Rescuing Immune Escape.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 05, 2025

125I seed brachytherapy synergized with PD-1 inhibitor imparts potent antitumor immune responses in hepatocellular carcinoma.

125I seed brachytherapy synergized with PD-1 inhibitor imparts potent antitumor immune responses in hepatocellular carcinoma.

Journal: Clinical and translational radiation oncology

Published: February 09, 2025

A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer.

A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer.

Journal: PloS one

Published: October 21, 2023

Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of 125I seed brachytherapy in HCC by near-infrared fluorescence.

Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of 125I seed brachytherapy in HCC by near-infrared fluorescence.

Journal: Frontiers in oncology

Published: January 12, 2023

Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR-6165/IGF1R axis.

Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR-6165/IGF1R axis.

Journal: Annals of the New York Academy of Sciences

Published: September 30, 2021

Emerging Opportunities for Combining Locoregional Therapy with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Emerging Opportunities for Combining Locoregional Therapy with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.

Journal: Current oncology reports

Published: June 30, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026